ARCA biopharma Inc (ABIO)
3.31
-0.01
(-0.30%)
USD |
NASDAQ |
Jun 14, 16:00
3.25
-0.06
(-1.81%)
After-Hours: 20:00
ARCA biopharma Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 23.09M |
| December 31, 2020 | 0.984M |
| September 30, 2020 | 42.06M |
| June 30, 2020 | 5.412M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.122M |
| September 30, 2019 | 0.568M |
| June 30, 2019 | 3.15M |
| March 31, 2019 | 2.964M |
| December 31, 2018 | -0.105M |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.207M |
| March 31, 2018 | 3.416M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.007M |
| September 30, 2017 | 3.947M |
| June 30, 2017 | 1.788M |
| March 31, 2017 | 0.105M |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.058M |
| September 30, 2015 | -0.20M |
| June 30, 2015 | 34.31M |
| March 31, 2015 | -0.055M |
| December 31, 2014 | -0.002M |
| September 30, 2014 | -0.051M |
| June 30, 2014 | -0.057M |
| March 31, 2014 | 8.133M |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.055M |
| June 30, 2013 | 17.82M |
| March 31, 2013 | 1.39M |
| December 31, 2012 | 0.508M |
| September 30, 2012 | 0.674M |
| June 30, 2012 | -0.067M |
| March 31, 2012 | -0.06M |
| December 31, 2011 | 1.426M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.122M
Minimum
Dec 2019
42.06M
Maximum
Sep 2020
3.757M
Average
--
Median
Mar 2020
Cash from Financing (Quarterly) Benchmarks
| Asensus Surgical Inc | 0.811M |
| Kintara Therapeutics Inc | 7.993M |
| Glaukos Corp | 13.17M |
| Helius Medical Technologies Inc | 1.463M |
| Perspective Therapeutics Inc | 166.33M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.528M |
| Free Cash Flow | -4.947M |
| Free Cash Flow Per Share (Quarterly) | -0.1054 |
| Free Cash Flow Yield | -10.35% |